TP53 and leukemia: Considering that our clonality analyses revealed TP53 and CHIP-associated gene mutations as disease-initiating and mutations of genes involved in signaling pathways and KMT2C as late events, KMT2C mutations seem to appear predominantly as the "second hit" driven by clonal selection pressure in abn(7) leukemia evolution.